论文部分内容阅读
目的:比较复方米非司酮和米非司酮配伍米索前列醇两种方案在终止早孕上的不同临床效果。方法:择取2014年7月到2015年7月这一年间于本院实行终止早孕操作的妇女共60例,分组并采取不同方案:研究组30例,配伍方案为复方米非司酮加米索前列醇;对照组30例,配伍方案为米非司酮加米索前列醇。对比两组的完全流产率及不良反应率。结果:对照组完全流产率比研究组高,P<0.05,统计学有差异。两组不良反应率相近,P>0.05,无统计学意义。结论:复方米非司酮与米索前列醇配伍,可以更有效地终止早孕,安全性也有保障。
Objective: To compare the different clinical effects of compound mifepristone and mifepristone with misoprostol in the termination of early pregnancy. Methods: Choose from July 2014 to July 2015 this year in our hospital to terminate the operation of early pregnancy, a total of 60 cases, divided into groups and take different programs: the study group of 30 cases, the compatibility program for the compound mifepristone plus Soprostenol; control group of 30 patients, compatibility program for mifepristone plus misoprostol. The complete abortion rate and adverse reaction rate were compared between the two groups. Results: The complete abortion rate of the control group was higher than that of the study group, P <0.05, statistically significant difference. Two groups of adverse reaction rates were similar, P> 0.05, no statistical significance. Conclusion: The compound mifepristone and misoprostol compatibility, can be more effective in terminating early pregnancy, safety is also guaranteed.